These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1666029)
1. Significance of proteolytic activity in 1,25-(OH)2D3-induced differentiation of HL-60 cells. Inaba M; Morii H; DeLuca HF Contrib Nephrol; 1991; 91():102-8. PubMed ID: 1666029 [TBL] [Abstract][Full Text] [Related]
2. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps. Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983 [TBL] [Abstract][Full Text] [Related]
3. Effects of uremic serum on 1,25-dihydroxyvitamin D3-induced differentiation of a human promyelocytic leukemia cell line, HL-60. Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H J Nutr Sci Vitaminol (Tokyo); 1991 Dec; 37 Suppl():S93-103. PubMed ID: 1668175 [TBL] [Abstract][Full Text] [Related]
4. Manipulation of thromboxane synthesis by novel 26,27-dialkyl analogues of 1 alpha,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells. Honda A; Mori Y; Ikekawa N; Raz A Eur J Pharmacol; 1992 Dec; 229(2-3):217-22. PubMed ID: 1337046 [TBL] [Abstract][Full Text] [Related]
5. 1,25(OH)2-vitamin D3 mediated changes in mRNA for c-myc and 1,25(OH)2D3 receptor in HL-60 cells and related subclones. Taoka T; Collins ED; Irino S; Norman AW Mol Cell Endocrinol; 1993 Sep; 95(1-2):51-7. PubMed ID: 8243807 [TBL] [Abstract][Full Text] [Related]
6. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Zhou JY; Norman AW; Akashi M; Chen DL; Uskokovic MR; Aurrecoechea JM; Dauben WG; Okamura WH; Koeffler HP Blood; 1991 Jul; 78(1):75-82. PubMed ID: 1648977 [TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426 [TBL] [Abstract][Full Text] [Related]
8. Effect of uremic serum on 1,25-dihydroxyvitamin D3-induced differentiation of human promyelocytic leukemia cell, HL-60. Inaba M; Okuno S; Koyama H; Ishimura E; Nishizawa Y; Morii H Nephron; 1993; 63(2):152-8. PubMed ID: 8383808 [TBL] [Abstract][Full Text] [Related]
9. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60. Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715 [TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells. Kizaki M; Norman AW; Bishop JE; Lin CW; Karmakar A; Koeffler HP Blood; 1991 Mar; 77(6):1238-47. PubMed ID: 1705836 [TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D. Honda A; Nakashima N; Mori Y; Katsumata T; Ishizuka S J Steroid Biochem Mol Biol; 1992 Jan; 41(1):109-12. PubMed ID: 1310414 [TBL] [Abstract][Full Text] [Related]
12. Monocytic differentiation of acute promyelocytic leukemia cells in response to 1,25-dihydroxyvitamin D3 is independent of nuclear receptor binding. Bhatia M; Kirkland JB; Meckling-Gill KA J Biol Chem; 1995 Jul; 270(27):15962-5. PubMed ID: 7608152 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of NaF-induced differentiation of HL-60 cells. Kawase T; Oguro A; Orikasa M; Burns DM J Bone Miner Res; 1996 Nov; 11(11):1676-87. PubMed ID: 8915775 [TBL] [Abstract][Full Text] [Related]
15. Stabilization of 1,25-dihydroxyvitamin D-3 receptor in the human leukemia cell line, HL-60, with diisopropylfluorophosphate. Inaba M; DeLuca HF Biochim Biophys Acta; 1989 Jan; 1010(1):20-7. PubMed ID: 2535782 [TBL] [Abstract][Full Text] [Related]
16. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3. Kuribayashi T; Tanaka H; Abe E; Suda T Endocrinology; 1983 Dec; 113(6):1992-8. PubMed ID: 6315339 [TBL] [Abstract][Full Text] [Related]
17. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3. Miyaura C; Abe E; Suda T; Kuroki T Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776 [TBL] [Abstract][Full Text] [Related]
18. Dephosphorylation of specific proteins in HL-60 cells by 1 alpha, 25-dihydroxyvitamin D3: possible involvement of cAMP-dependent protein kinase. Ueda T; Sawada H; Okuda T; Yumoto Y; Kato Y; Ogawa K; Tashima M; Yoshida Y; Okuma M Leuk Res; 1991; 15(10):927-34. PubMed ID: 1656150 [TBL] [Abstract][Full Text] [Related]
19. Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes. Matsumoto K; Azuma Y; Kiyoki M; Okumura H; Hashimoto K; Yoshikawa K Biochim Biophys Acta; 1991 May; 1092(3):311-8. PubMed ID: 1646640 [TBL] [Abstract][Full Text] [Related]
20. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells. Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]